* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on April 29 for the
period ending March 31 2024
* The Owings Mills Maryland-based company is expected to
report a
51.6% decrease in revenue to $168.9 million from $348.98 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.The company's guidance on February 20 2024,
for the period ended March 31, was for revenue between $155.00
million and $175.00 million.
* LSEG's mean analyst estimate for Medifast Inc is for
earnings
of 78 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 7.3%
in the last three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$37.50, above its last closing price of $33.50.
This summary was machine generated April 26 at 21:14 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)